Mark N Milton

Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches

Philip J Lowe, Martin Fink, Mark N Milton, 2017, Clinical pharmacology and therapeutics.

P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.

Mark N Milton, Ning Liu, Suresh K Balani, 2010, Drug metabolism letters.